MedTech Actuator Origin -- Diag-Nose.io founder makes Forbes 30 Under 30 Asia list
MedTech Actuator is thrilled to celebrate a significant achievement by alumnus Eldin Rostom. Eldin, the visionary CEO and Founder of Diag-Nose.io, has earned a place on the Forbes 30 Under 30 Asia list for Healthcare and Science in 2024.
At the heart of Diag-Nose.io's innovation is their flagship product, RhinoMAP -- an AI-driven tool that leverages protein signatures to expedite the diagnosis process for patients with chronic respiratory conditions. With over 500 million people worldwide affected by chronic respiratory disorders, the impact of RhinoMAP is profound.
"Our mission is to improve a billion lives globally. RhinoMAP is designed to overcome the lengthy diagnosis process and help patients breathe better and live longer."
-- Eldin Rostom, CEO, Diag-Nose.io
From patient to pioneer
Eldin's journey in healthcare innovation is as personal as it is professional. Born with a rare disease (Toxoplasmosis), Eldin spent much of his early life in and out of hospitals. This firsthand experience with the challenges of healthcare ignited his passion for using technology to improve patient outcomes.
MedTech Actuator: a launchpad for success
Eldin's path to success was significantly shaped by his participation in MedTech Actuator Origin in 2019. The program provided him with critical insights into medtech commercialisation, regulatory landscapes, and intellectual property.
"MedTech Actuator Origin gave us the conviction to continue on with the startup journey. We met some pretty amazing mentors, friends, and advisors through the program that are still part of our journey to this day."
-- Eldin Rostom
Looking ahead
Joining the Forbes 30 Under 30 Asia 2024 cohort has already begun to open new doors for Diag-Nose.io, attracting interest from investors and the media. Eldin hopes this recognition will lead to more collaborations and partnerships, enabling the company to scale its impact and reach even more patients in need.
Apply for MedTech Actuator Origin 2024
Are you driven to change the face of healthcare like Eldin? Applications are open for MedTech Actuator Origin 2024 until Monday, August 26.
Whether you're a researcher, scientist, clinician or student, MedTech Actuator Origin is looking for passionate entrepreneurs poised to transform healthcare. The winner of MedTech Actuator Origin will receive a $15k cash and in-kind prize pack.
MedTech Actuator Origin is supported by LaunchVic.